Q32 Bio logo

Q32 BioNASDAQ: QTTB

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

28 March 2018

Next earnings report:

30 August 2024

Last dividends:

N/A

Next dividends:

N/A
$226.66 M
-39%vs. 3y high
56%vs. sector
-vs. 3y high
-vs. sector
-39%vs. 3y high
82%vs. sector
-vs. 3y high
-vs. sector

Price

after hours | Mon, 01 Jul 2024 21:23:26 GMT
$18.98+$1.03(+5.74%)

Dividend

No data over the past 3 years

Analysts recommendations

Institutional Ownership

QTTB Latest News

Q32 Bio Joins Russell 3000® Index
prnewswire.com01 July 2024 Sentiment: -

WALTHAM, Mass. , July 1, 2024 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced that the company is joining the broad-market Russell 3000® Index at the conclusion of the 2024 Russell Indexes annual reconstitution, effective upon the U.S. market opening today, July 1, 2024.

What type of business is Q32 Bio?

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body’s first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32’s complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

What sector is Q32 Bio in?

Q32 Bio is in the Healthcare sector

What industry is Q32 Bio in?

Q32 Bio is in the Biotechnology industry

What country is Q32 Bio from?

Q32 Bio is headquartered in United States

When did Q32 Bio go public?

Q32 Bio initial public offering (IPO) was on 28 March 2018

What is Q32 Bio website?

https://www.q32bio.com

Is Q32 Bio in the S&P 500?

No, Q32 Bio is not included in the S&P 500 index

Is Q32 Bio in the NASDAQ 100?

No, Q32 Bio is not included in the NASDAQ 100 index

Is Q32 Bio in the Dow Jones?

No, Q32 Bio is not included in the Dow Jones index

When does Q32 Bio report earnings?

The next expected earnings date for Q32 Bio is 30 August 2024